These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Early mortality and loss to follow-up in HIV-infected children starting antiretroviral therapy in Southern Africa. Fenner L; Brinkhof MW; Keiser O; Weigel R; Cornell M; Moultrie H; Prozesky H; Technau K; Eley B; Vaz P; Pascoe M; Giddy J; Van Cutsem G; Wood R; Egger M; Davies MA; J Acquir Immune Defic Syndr; 2010 Aug; 54(5):524-32. PubMed ID: 20588185 [TBL] [Abstract][Full Text] [Related]
4. Same-day antiretroviral therapy is associated with increased loss to follow-up in South African public health facilities: a prospective cohort study of patients diagnosed with HIV. Joseph Davey D; Kehoe K; Serrao C; Prins M; Mkhize N; Hlophe K; Sejake S; Malone T J Int AIDS Soc; 2020 Jun; 23(6):e25529. PubMed ID: 32510186 [TBL] [Abstract][Full Text] [Related]
5. Mortality and loss to follow-up among HIV-infected persons on long-term antiretroviral therapy in Latin America and the Caribbean. Carriquiry G; Fink V; Koethe JR; Giganti MJ; Jayathilake K; Blevins M; Cahn P; Grinsztejn B; Wolff M; Pape JW; Padgett D; Madero JS; Gotuzzo E; McGowan CC; Shepherd BE J Int AIDS Soc; 2015; 18(1):20016. PubMed ID: 26165322 [TBL] [Abstract][Full Text] [Related]
6. Factors associated with attrition, mortality, and loss to follow up after antiretroviral therapy initiation: data from an HIV cohort study in India. Alvarez-Uria G; Naik PK; Pakam R; Midde M Glob Health Action; 2013 Sep; 6():21682. PubMed ID: 24028937 [TBL] [Abstract][Full Text] [Related]
7. Predictors of loss to follow-up among children in the first and second years of antiretroviral treatment in Johannesburg, South Africa. Sengayi M; Dwane N; Marinda E; Sipambo N; Fairlie L; Moultrie H Glob Health Action; 2013 Jan; 6():19248. PubMed ID: 23364098 [TBL] [Abstract][Full Text] [Related]
8. Changes in programmatic outcomes during 7 years of scale-up at a community-based antiretroviral treatment service in South Africa. Nglazi MD; Lawn SD; Kaplan R; Kranzer K; Orrell C; Wood R; Bekker LG J Acquir Immune Defic Syndr; 2011 Jan; 56(1):e1-8. PubMed ID: 21084996 [TBL] [Abstract][Full Text] [Related]
9. Outcomes of Nigeria's HIV/AIDS Treatment Program for Patients Initiated on Antiretroviral Treatment between 2004-2012. Dalhatu I; Onotu D; Odafe S; Abiri O; Debem H; Agolory S; Shiraishi RW; Auld AF; Swaminathan M; Dokubo K; Ngige E; Asadu C; Abatta E; Ellerbrock TV PLoS One; 2016; 11(11):e0165528. PubMed ID: 27829033 [TBL] [Abstract][Full Text] [Related]
10. When to start antiretroviral therapy in children aged 2-5 years: a collaborative causal modelling analysis of cohort studies from southern Africa. Schomaker M; Egger M; Ndirangu J; Phiri S; Moultrie H; Technau K; Cox V; Giddy J; Chimbetete C; Wood R; Gsponer T; Bolton Moore C; Rabie H; Eley B; Muhe L; Penazzato M; Essajee S; Keiser O; Davies MA; PLoS Med; 2013 Nov; 10(11):e1001555. PubMed ID: 24260029 [TBL] [Abstract][Full Text] [Related]
11. Variations in the characteristics and outcomes of children living with HIV following universal ART in sub-Saharan Africa (2006-17): a retrospective cohort study. Iyun V; Technau KG; Vinikoor M; Yotebieng M; Vreeman R; Abuogi L; Desmonde S; Edmonds A; Amorissani-Folquet M; Davies MA; Lancet HIV; 2021 Jun; 8(6):e353-e362. PubMed ID: 33932330 [TBL] [Abstract][Full Text] [Related]
12. Age in antiretroviral therapy programmes in South Africa: a retrospective, multicentre, observational cohort study. Cornell M; Johnson LF; Schomaker M; Tanser F; Maskew M; Wood R; Prozesky H; Giddy J; Stinson K; Egger M; Boulle A; Myer L; Lancet HIV; 2015 Sep; 2(9):e368-75. PubMed ID: 26423550 [TBL] [Abstract][Full Text] [Related]
13. Time-varying age- and CD4-stratified rates of mortality and WHO stage 3 and stage 4 events in children, adolescents and youth 0 to 24 years living with perinatally acquired HIV, before and after antiretroviral therapy initiation in the paediatric IeDEA Global Cohort Consortium. Desmonde S; Neilan AM; Musick B; Patten G; Chokephaibulkit K; Edmonds A; Duda SN; Malateste K; Wools-Kaloustian K; Ciaranello AL; Davies MA; Leroy V; J Int AIDS Soc; 2020 Oct; 23(10):e25617. PubMed ID: 33034417 [TBL] [Abstract][Full Text] [Related]
14. Early severe HIV disease precedes early antiretroviral therapy in infants: Are we too late? Innes S; Lazarus E; Otwombe K; Liberty A; Germanus R; Van Rensburg AJ; Grobbelaar N; Hurter T; Eley B; Violari A; Cotton MF J Int AIDS Soc; 2014; 17(1):18914. PubMed ID: 24925044 [TBL] [Abstract][Full Text] [Related]
15. Early virological suppression with three-class antiretroviral therapy in HIV-infected African infants. Prendergast A; Mphatswe W; Tudor-Williams G; Rakgotho M; Pillay V; Thobakgale C; McCarthy N; Morris L; Walker BD; Goulder P AIDS; 2008 Jul; 22(11):1333-43. PubMed ID: 18580613 [TBL] [Abstract][Full Text] [Related]
16. Access to antiretroviral therapy in HIV-infected children aged 0-19 years in the International Epidemiology Databases to Evaluate AIDS (IeDEA) Global Cohort Consortium, 2004-2015: A prospective cohort study. Desmonde S; Tanser F; Vreeman R; Takassi E; Edmonds A; Lumbiganon P; Pinto J; Malateste K; McGowan C; Kariminia A; Yotebieng M; Dicko F; Yiannoutsos C; Mubiana-Mbewe M; Wools-Kaloustian K; Davies MA; Leroy V; PLoS Med; 2018 May; 15(5):e1002565. PubMed ID: 29727458 [TBL] [Abstract][Full Text] [Related]
17. Twelve-year mortality in adults initiating antiretroviral therapy in South Africa. Cornell M; Johnson LF; Wood R; Tanser F; Fox MP; Prozesky H; Schomaker M; Egger M; Davies MA; Boulle A; J Int AIDS Soc; 2017 Sep; 20(1):21902. PubMed ID: 28953328 [TBL] [Abstract][Full Text] [Related]
18. Determinants of loss to follow-up among HIV positive patients receiving antiretroviral therapy in a test and treat setting: A retrospective cohort study in Masaka, Uganda. Kiwanuka J; Mukulu Waila J; Muhindo Kahungu M; Kitonsa J; Kiwanuka N PLoS One; 2020; 15(4):e0217606. PubMed ID: 32255796 [TBL] [Abstract][Full Text] [Related]
19. Growth and Mortality Outcomes for Different Antiretroviral Therapy Initiation Criteria in Children Ages 1-5 Years: A Causal Modeling Analysis. Schomaker M; Davies MA; Malateste K; Renner L; Sawry S; N'Gbeche S; Technau KG; Eboua F; Tanser F; Sygnaté-Sy H; Phiri S; Amorissani-Folquet M; Cox V; Koueta F; Chimbete C; Lawson-Evi A; Giddy J; Amani-Bosse C; Wood R; Egger M; Leroy V; Epidemiology; 2016 Mar; 27(2):237-46. PubMed ID: 26479876 [TBL] [Abstract][Full Text] [Related]
20. Temporal trends in treatment outcomes for HIV-1 and HIV-2-infected adults enrolled in Côte d'Ivoire's national antiretroviral therapy program. Auld AF; Ekra KA; Shiraishi RW; Tuho MZ; Kouakou JS; Mohamed F; Ettiègne-Traoré V; Sabatier J; Essombo J; Adjorlolo-Johnson G; Marlink R; Ellerbrock TV PLoS One; 2014; 9(5):e98183. PubMed ID: 24866468 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]